FDA News

FDA Orders Juul Labs to Remove all Products from US Market, Denies Marketing Authorization
June 23, 2022

The FDA today denied Juul Labs' premarket tobacco product applications and ordered all products removed from shelves nationwide, ending a 2-year review.

FDA Announces Plans for Potential Rule to Set Nicotine Limit in Tobacco Products
June 22, 2022

A cap on nicotine levels in cigarettes and other combustible tobacco products may be enforced sooner rather than later.

FDA Authorizes Pfizer and Moderna COVID-19 Vaccines for Children 6 Months and Up
June 17, 2022

The FDA authorized emergency use of Moderna and Pfizer-BioNTech's COVID-19 vaccines for use in children as young as 6 months old.

Novel FDA-cleared AFib History Software and Medication App Part of Newly Announced Apple Watch Update
June 13, 2022

Apple recently announced a new software release that will allow Apple Watch users access to health care-focused features and apps.

FDA Advisory Committee Recommends Emergency Use Authorization of Novavax COVID-19 Vaccine for Persons Aged 18 Years and Older
June 08, 2022

If EUA is granted, the Novavax COVID-19 vaccine would be the first protein-based COVID-19 vaccine available in the US.

CGM News: FreeStyle Libre 3 Cleared by FDA for Persons Aged 4 Years and Older with Diabetes
June 02, 2022

The Abbott FreeStyle Libre 3 is the smallest, thinnest, and most accurate 14-day CGM with a 7.9% MARD, the company says.

Pfizer Wins Fast Track Designation for Potential NASH Drug Combination
May 26, 2022

Early phase 2a study results of a combination of the 2 agents previously evaluated as NASH monotherapies led to the FDA award for Pfizer.

FDA Grants EUA for At-home Triple Test: COVID-19, Influenza, RSV
May 23, 2022

The Labcorp home test, available without a prescription, is delivered overnight and includes a return envelope. Results are available in 1-2 days.

FDA Approved Dupilumab as the First Treatment for Eosinophilic Esophagitis
May 23, 2022

Dupilumab is approved for the treatment of eosinophilic esophagitis in patients aged ≥12 years weighing at least 40 kgs.

FDA Authorizes Pfizer-BioNTech COVID-19 Booster for Children Aged 5 to 11 Years
May 17, 2022

Children aged 5 to 11 years can receive a single dose booster shot 5 months after completing a primary 2-dose series of the Pfizer COVID-19 vaccine, FDA says.